[Comparative evaluation of the efficacy of fluorofur (Ftorafur) and 5-fluorouracil (5-ftouracil) in the treatment of breast cancer].
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003967:Diarrhea / Q000139:chemically induced; D004341:Drug Evaluation; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005663:Furans / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced
D000970:Antineoplastic Agents; D005663:Furans; D005472:Fluorouracil
Valutazione comparativa della efficacia del flourofuro (Ftorafur) e del 5-fluorouracile (5-ftouracil) per la cura del cancro della ghiandola mammaria